Medical News Home

The Global Viral Forecasting Initiative (GVFI), a nonprofit research initiative dedicated to preventing pandemics, has received $11 million dollars from Google.org and The Skoll Foundation. The support, which includes $5.5 million dollars from each organization, represents the largest grant to date from Google.org.

A single vaccine could be used to protect chickens, cats and humans against deadly flu pandemics, according to an article published in the November issue of the Journal of General Virology. The vaccine protects birds and mammals against different flu strains and can even be given to birds while they are still in their eggs, allowing the mass vaccination of wild birds.

Owners of small or backyard poultry flocks are invited to attend a free information session on how to help prevent and detect poultry diseases such as avian influenza. The session is being hosted by the Canadian Food Inspection Agency (CFIA) and the B.C. Ministry of Agriculture and Lands (BCMAL). Area bird owners and the general public are welcome to join from 6:00 p.m. to 9:00 p.m.

Queen’s University Belfast scientists are involved in two international projects aimed to protect Northern Ireland’s agri-food industry from Bird Flu and African Swine Fever, a disease which kills pigs. Working with colleagues from other EU-member states and the Far East in the FLUTEST project they are providing improved diagnosis and early warning systems for bird flu.

A new study shows that individuals immunized six years earlier with an MF59 adjuvanted H5N3 (clade 0) vaccine mounted a protective immune response seven days after a single immunization with an H5N1 (clade 1) vaccine containing the Novartis proprietary adjuvant MF59. The immune response was broadly cross reactive and covered all H5N1 clades known to date.

Results from two new clinical studies announced at the Third European Influenza Conference (ESWI) demonstrate that Prepandrix™, GlaxoSmithKline’s (GSK) H5N1 adjuvanted pre-pandemic influenza vaccine, confers broad cross-clade immunity that is maintained when the second dose is given many months after the first dose, and even if the second dose is formulated from a different H5N1 strain.

Queen’s University Belfast scientists are involved in two international projects aimed to protect Northern Ireland’s agri-food industry from Bird Flu and African Swine Fever, a disease which kills pigs. Working with colleagues from other EU-member states and the Far East in the FLUTEST project they are providing improved diagnosis and early warning systems for bird flu.

Scientists funded by the Wellcome Trust are to examine what is preventing the H5N1 avian influenza virus from causing a human pandemic and what mutations are required to realise its deadly potential. The research could hold the key to early identification of a potential influenza pandemic, and to developing drugs and a vaccine.

Researchers at Rutgers University and The University of Texas at Austin have reported a discovery that could help scientists develop drugs to fight the much-feared bird flu and other virulent strains of influenza.

Scientists at the University of Pittsburgh Center for Vaccine Research have been awarded $3.6 million from the National Institutes of Health to conduct animal studies of vaccines designed to protect against the most common and deadliest strain of avian flu, H5N1.